Blantz R C
Am J Kidney Dis. 1987 Jul;10(1 Suppl 1):2-6.
Evidence has accumulated that angiotensin II (AII) exerts multiple influences upon renal function through effects on vascular, glomerular, and tubular structures. Infusion of AII alters glomerular ultrafiltration by decreasing nephron plasma flow, increasing glomerular capillary hydrostatic pressure (PG) and the hydrostatic pressure gradient (delta P) due to increases in both afferent and efferent arteriolar vascular resistance, and effecting a reduction in the glomerular ultrafiltration coefficient (LpA), the product of glomerular membrane hydraulic conductivity and effective surface area for ultrafiltration. Spontaneous increases in intrarenal AII generation, such as observed in chronic NaCl depletion, also produce reductions in nephron plasma flow, increases in delta P, and major reductions in LpA. Angiotensin-converting enzyme inhibitor and saralasin administration prevent these alterations in plasma flow, delta P, and LpA. These AII-induced alterations in LpA may be mediated by AII effects upon the glomerular mesangial cell since AII receptors are expressed and this cell contracts in vitro in the presence of AII. Multiple studies have shown a positive effect of AII (approximately 10(-11) mol/L) on proximal tubular reabsorption, an effect independent of AII effects on peritubular physical factors. These AII effects upon the proximal tubule are clearly independent of interaction with adrenergic influences. AII also influences other mesangial cell functions such as uptake of macromolecules from the circulation. AII also exerts effects by influencing the functional expression of renal adrenergic activity, as demonstrated by studies with renal nerve stimulation in the presence and absence of angiotensin-converting enzyme inhibitor and saralasin. Inhibition of AII activity also clearly suppresses tubuloglomerular activity and the PG response to alterations in distal tubular flow rates.(ABSTRACT TRUNCATED AT 250 WORDS)
已有证据表明,血管紧张素II(AII)通过对血管、肾小球和肾小管结构的作用,对肾功能产生多种影响。输注AII会改变肾小球超滤,其机制包括降低肾血浆流量、增加肾小球毛细血管静水压(PG)以及由于入球和出球小动脉血管阻力增加导致的静水压梯度(ΔP)增加,还会使肾小球超滤系数(LpA)降低,LpA是肾小球膜水力传导率与超滤有效表面积的乘积。肾内AII生成的自发增加,如在慢性氯化钠缺乏时观察到的情况,也会导致肾血浆流量减少、ΔP增加以及LpA大幅降低。给予血管紧张素转换酶抑制剂和沙拉新可防止血浆流量、ΔP和LpA的这些改变。AII诱导的LpA改变可能由AII对肾小球系膜细胞的作用介导,因为存在AII受体且该细胞在体外AII存在时会收缩。多项研究表明,AII(约10⁻¹¹ mol/L)对近端肾小管重吸收有积极作用,该作用独立于AII对肾小管周围物理因素的影响。AII对近端小管的这些作用显然独立于与肾上腺素能影响的相互作用。AII还影响其他系膜细胞功能,如从循环中摄取大分子。AII还通过影响肾肾上腺素能活性的功能表达发挥作用,在有和没有血管紧张素转换酶抑制剂及沙拉新的情况下进行肾神经刺激的研究证明了这一点。抑制AII活性也明显抑制肾小管 - 肾小球活动以及PG对远端小管流速改变的反应。(摘要截短于250字)